EVE Health Group Limited (ASX: EVE) - Share Price

- Current share price for EVE : $0.015

EVE Health Group Limited (EVE) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a vertically integrated producer of branded nutrition, health and wellness products. The Company has global reach and application to fast-growing markets across Australia and New Zealand, Asia Pacific and North America.

EVE General Information ⁺

ASX Code	EVE
Website	http://www.evehealthgroup.com.au
Industry/Sector	Packaged Foods & Meats
Market Cap ($M)	5
EVE Share Price	$0.015
Day High	$0.015
Day Low	$0.015
Last Close	$0.015
EVE Share Price Movement	- ( No change )

Prices as at 16:40, 23 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

EVE Health Group Limited (EVE) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from EVE Health Group Limited (EVE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EVE Health Group Limited (EVE) price-sensitive announcements

EVE - Appendix 4E

EVE Health Group Limited’s Appendix 4E Results for Announcement to the Market for the fina

EVE Health Group Limited (EVE)
31 Aug 2026 | 5:18 PM

EVE - Quarterly Activities/Appendix 4C Cash Flow Report - Amended

EVE Health Group Limited reported significant progress in its clinical and operational act

EVE Health Group Limited (EVE)
7 Aug 2026 | 12:43 PM

EVE - Quarterly Activities/Appendix 4C Cash Flow Report

EVE Health Group Limited, an Australian life sciences company, has made significant stride

EVE Health Group Limited (EVE)
31 Jul 2026 | 9:47 AM

EVE - Eve Initiates Pilot Clinical Study for Libbo ED Film

EVE Health Group Limited, an Australian life sciences company, announced the initiation of

EVE Health Group Limited (EVE)
16 Jun 2026 | 8:21 AM

EVE Health Group Limited (EVE) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Letter to Shareholders - AGM Notice of Meeting	16 Oct 2026 12:04PM	$0.015	$0.015	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Notice of Annual General Meeting/Proxy Form	16 Oct 2026 12:04PM	$0.015	$0.015	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Change of Director's Interest Notice x 3	5 Oct 2026 2:31PM	$0.015	$0.015	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Notification of cessation of securities - EVE	5 Oct 2026 2:18PM	$0.015	$0.015	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Date of AGM	22 Sep 2026 1:43PM	$0.017	$0.015	fallen by 11.76%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$5	Coffee Microcaps Conference Presentation	22 Sep 2026 9:10AM	$0.018	$0.015	fallen by 16.67%

EVE Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$1.89	-$0.70	-38.70%	0.00%	0.0%
2025A	-$1.45	-$1.10	-11.70%	0.00%	0.0%
2024A	-$1.58	-$1.20	-31.80%	0.00%	0.0%

EVE Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
The a2 Milk Company Limited (A2M)	$5,075M	-0.5230	0.9636	0.2969	56.4372	28.7423	22.1622	2.25%	2.43%	3.13%
Bega Cheese Limited (BGA)	$1,957M	-3.8555	0.1867	0.2091	27.9110	23.5208	19.4529	2.27%	2.66%	3.28%
Cobram Estate Olives Limited (CBO)	$1,250M	-0.7456	0.0000	0.0000	90.3114	0.0000	0.0000	0.00%	0.00%	0.00%
EVE Health Group Limited (EVE)	$5M	-0.3868	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Ricegrowers Limited (SGLLV)	$987M	-0.0114	-0.2480	0.1948	13.9160	18.5065	15.4891	4.91%	4.91%	4.91%

EVE Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	1.34	0.00
Market	0.30	13.30	1.03	0.72
Sector	0.31	13.60	0.83	0.90

EVE Directors

Name	Position	Start Date
Dr Stuart Gunzburg	Chief Scientific Officer, Executive Director	12 Jun 2025
Mr Rodney Andrew Hannington	Non-Executive Chairman, Non-Executive Director	14 Jun 2022
Mr Gregory William (Bill) Fry	Non-Executive Director	18 Aug 2009

EVE Health Group Limited (EVE) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
21 May 2026	FRY, Gregory	Buy	Indirect Shares	850,000	$0.021	$17,850.000
8 May 2026	GUNZBURG, Stuart	Issued	Indirect Shares	500,000	$0.020	$10,000.000
2 Jan 2026	GUNZBURG, Stuart	Buy	Indirect Shares	200,000	$0.021	$4,200.000

See all changes in directors' interest & trades for EVE Health Group Limited (EVE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EVE Management

Name	Position
Steven Jackson	Company Secretary

EVE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EVE Health Group Limited (EVE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
51,608,528 (14.65%)	A-WON Pharma Pty Ltd
27,510,581 (7.81%)	Stuart Gunzburg
20,502,645 (5.82%)	Aqa Corporation Pty Ltd

EVE Calendar of Events

Date	Event
30 August 2027	Report (Annual)
30 August 2027	Report (Prelim)
26 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us